Phapros Tbk PT (PEHA) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.064x

Based on the latest financial reports, Phapros Tbk PT (PEHA) has a cash flow conversion efficiency ratio of 0.064x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp27.30 Billion ≈ $1.60 Million USD) by net assets (Rp428.24 Billion ≈ $25.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Phapros Tbk PT to measure how many days the company can operate on defensive assets alone.

Phapros Tbk PT - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Phapros Tbk PT's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Phapros Tbk PT Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Phapros Tbk PT ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
FirstGroup PLC LSE:FGP	0.314x
Bayhorse Silver Inc V:BHS	6.385x
Smith Micro Software Inc NASDAQ:SMSI	-0.107x
SSR Inc KQ:275630	0.043x
Park & Bellheimer AG F:PKB	0.143x
Grand Pacific Petrochemical Corp Pref TW:1312A	-0.026x
Bflysoft Co. Ltd. KQ:148780	0.134x
Next Biometrics Group ASA OL:NEXT	-0.241x

Annual Cash Flow Conversion Efficiency for Phapros Tbk PT (2011–2025)

The table below shows the annual cash flow conversion efficiency of Phapros Tbk PT from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Phapros Tbk PT market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Rp427.47 Billion ≈ $25.05 Million	Rp70.98 Billion ≈ $4.16 Million	0.166x	-53.79%
2024-12-31	Rp393.12 Billion ≈ $23.04 Million	Rp141.28 Billion ≈ $8.28 Million	0.359x	+2016.64%
2023-12-31	Rp770.33 Billion ≈ $45.14 Million	Rp-14.44 Billion ≈ $-846.35K	-0.019x	-151.56%
2022-12-31	Rp771.82 Billion ≈ $45.23 Million	Rp28.07 Billion ≈ $1.64 Million	0.036x	-85.81%
2021-12-31	Rp740.98 Billion ≈ $43.42 Million	Rp189.92 Billion ≈ $11.13 Million	0.256x	-26.81%
2020-12-31	Rp740.91 Billion ≈ $43.41 Million	Rp259.48 Billion ≈ $15.20 Million	0.350x	+11694.31%
2019-12-31	Rp821.61 Billion ≈ $48.14 Million	Rp-2.48 Billion ≈ $-145.42K	-0.003x	+96.86%
2018-12-31	Rp789.80 Billion ≈ $46.28 Million	Rp-75.91 Billion ≈ $-4.45 Million	-0.096x	-166.07%
2017-12-31	Rp701.39 Billion ≈ $41.10 Million	Rp102.03 Billion ≈ $5.98 Million	0.145x	-20.68%
2016-12-31	Rp622.08 Billion ≈ $36.45 Million	Rp114.08 Billion ≈ $6.68 Million	0.183x	+17.67%
2015-12-31	Rp449.72 Billion ≈ $26.35 Million	Rp70.09 Billion ≈ $4.11 Million	0.156x	-24.29%
2014-12-31	Rp408.25 Billion ≈ $23.92 Million	Rp84.04 Billion ≈ $4.92 Million	0.206x	+313.18%
2013-12-31	Rp391.40 Billion ≈ $22.93 Million	Rp19.50 Billion ≈ $1.14 Million	0.050x	-67.11%
2012-12-31	Rp375.63 Billion ≈ $22.01 Million	Rp56.90 Billion ≈ $3.33 Million	0.151x	+288.78%
2011-12-31	Rp339.17 Billion ≈ $19.87 Million	Rp-27.22 Billion ≈ $-1.59 Million	-0.080x	--

About Phapros Tbk PT

JK:PEHA Indonesia Drug Manufacturers - Specialty & Generic

Market Cap

$12.50 Million

Rp213.36 Billion IDR

Market Cap Rank

#26485 Global

#582 in Indonesia

Share Price

Rp254.00

Change (1 day)

-2.31%

52-Week Range

Rp214.00 - Rp384.00

All Time High

Rp2996.89